Mark A. Sirgo - 01 Jul 2022 Form 4/A - Amendment Insider Report for 9 METERS BIOPHARMA, INC.

Role
Director
Signature
/s/ Bethany Sensenig, as power of attorney
Issuer symbol
N/A
Transactions as of
01 Jul 2022
Net transactions value
+$42,962
Form type
4/A - Amendment
Filing time
22 Jul 2022, 16:21:02 UTC
Date Of Original Report
06 Jul 2022
Previous filing
23 Jun 2022
Next filing
31 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NMTR Common stock Award $42,962 +175,000 +13% $0.2455 1,560,428 01 Jul 2022 Direct F1
holding NMTR Common stock 21,485 01 Jul 2022 by spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $0.21 to $0.27, inclusive. The reporting person undertakes to provide to 9 Meters Biopharma, Inc., any security holder of 9 Meters Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

Remarks:

This amendment on Form 4/A is being filed with the Securities and Exchange Commission to amend the Form 4, originally filed by the reporting person on July 6, 2022, which incorrectly totaled the amount of securities owned following the reported transaction. As of the date of filing this Form 4/A, the reporting person directly owns 1,560,427.55 shares of common stock and 21,485 shares of common stock are held by the reporting person's spouse.